Kent W. Hunter

12.6k total citations · 1 hit paper
123 papers, 5.9k citations indexed

About

Kent W. Hunter is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Kent W. Hunter has authored 123 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 95 papers in Molecular Biology, 39 papers in Cancer Research and 35 papers in Genetics. Recurrent topics in Kent W. Hunter's work include Cancer Genomics and Diagnostics (24 papers), Genomics and Chromatin Dynamics (20 papers) and Cancer Cells and Metastasis (18 papers). Kent W. Hunter is often cited by papers focused on Cancer Genomics and Diagnostics (24 papers), Genomics and Chromatin Dynamics (20 papers) and Cancer Cells and Metastasis (18 papers). Kent W. Hunter collaborates with scholars based in United States, United Kingdom and Canada. Kent W. Hunter's co-authors include Nigel P.S. Crawford, Jude Alsarraj, Luanne Lukes, Jeffrey E. Green, Renard C. Walker, Laura Vera‐Ramirez, Suman K. Vodnala, Robert W. Williams, Kenneth H. Buetow and David W. Threadgill and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Kent W. Hunter

118 papers receiving 5.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Autophagy promotes the survival of dormant breast cancer cells and metastatic tumour recurrence

2018 336 citations Laura Vera‐Ramirez, Suman K. Vodnala et al. profile →

Peers

Countries citing papers authored by Kent W. Hunter

Since Specialization

Citations

This map shows the geographic impact of Kent W. Hunter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kent W. Hunter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kent W. Hunter more than expected).

Fields of papers citing papers by Kent W. Hunter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kent W. Hunter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kent W. Hunter. The network helps show where Kent W. Hunter may publish in the future.

Co-authorship network of co-authors of Kent W. Hunter

This figure shows the co-authorship network connecting the top 25 collaborators of Kent W. Hunter. A scholar is included among the top collaborators of Kent W. Hunter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kent W. Hunter. Kent W. Hunter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	SMARCD1 is an essential expression-restricted metastasis modifier 2024 ·Communications Biology ·Christina R. Ross, Li-Yun Gong, Lisa M. Jenkins, (unknown), (unknown), Kent W. Hunter	1
2	Resf1 is a compound G4 quadruplex-associated tumor suppressor for triple negative breast cancer 2024 ·PLoS Genetics ·(unknown), (unknown), (unknown), Ruhul Amin, (unknown), Christina R. Ross, Howard H. Yang, Maxwell P. Lee, Kent W. Hunter	2
3	Comparative analysis and classification of highly divergent mouse rDNA units based on their intergenic spacer (IGS) variability 2024 ·NAR Genomics and Bioinformatics ·Jung-Hyun Kim, Ramaiah Nagaraja, (unknown), Vladimir N. Noskov, Mikhail Liskovykh, Hee-Sheung Lee, (unknown), Takehiko Kobayashi, Kent W. Hunter, David Schlessinger, Natalay Kouprina, Svetlana A. Shabalina, Vladimir Larionov	1
4	Dysregulation of Mitochondrial Translation Caused by CBFB Deficiency Cooperates with Mutant PIK3CA and Is a Vulnerability in Breast Cancer 2023 ·Cancer Research ·(unknown), (unknown), Hualong Yan, (unknown), (unknown), Gamze Ayaz, Andy D. Tran, Laura Vera‐Ramirez, Howard H. Yang, Aleksandra M. Michalowski, Michael J. Kruhlak, Maxwell Lee, Kent W. Hunter, Jing Huang	6
5	Host CLIC4 expression in the tumor microenvironment is essential for breast cancer metastatic competence 2022 ·PLoS Genetics ·Vanesa C. Sanchez, Howard H. Yang, (unknown), (unknown), (unknown), Justin Lack, Jennifer E. Dwyer, R. Mark Simpson, Christophe Cataisson, (unknown), Ji Luo, Kent W. Hunter, Stuart H. Yuspa	9
6	The genomic landscape of metastasis in treatment-naïve breast cancer models 2020 ·PLoS Genetics ·Christina R. Ross, Karol Szczepanek, Maxwell Lee, Howard H. Yang, (unknown), (unknown), Kent W. Hunter	16
7	Metastasis-Specific Gene Expression in Autochthonous and Allograft Mouse Mammary Tumor Models: Stratification and Identification of Targetable Signatures 2020 ·Molecular Cancer Research ·Christina R. Ross, Karol Szczepanek, Maxwell Lee, Howard H. Yang, Cody J. Peer, (unknown), (unknown), Zhi-Wei Lin, (unknown), William D. Figg, Kent W. Hunter	14
8	Aicardi-Goutières syndrome gene Rnaseh2c is a metastasis susceptibility gene in breast cancer 2019 ·PLoS Genetics ·(unknown), (unknown), Suman K. Vodnala, Howard H. Yang, Randall A. Dass, Ying Hu, Maxwell P. Lee, Robert J. Crouch, Kent W. Hunter	11
9	Receptor tyrosine kinase activation of RhoA is mediated by AKT phosphorylation of DLC1 2017 ·The Journal of Cell Biology ·Brajendra K. Tripathi, (unknown), Xiaolan Qian, Ming Zhou, Philipp Mertins, Dunrui Wang, Alex G. Papageorge, Sergey G. Tarasov, Kent W. Hunter, Steven A. Carr, Douglas R. Lowy	30
10	CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ 2015 ·Cancer Research ·(unknown), Jian Jiang, Yanli Pang, (unknown), Michael M. Lizardo, Xin‐hua Liang, Kent W. Hunter, Chand Khanna, Christine Hollander, Yang Li	61
11	Inherited Variation in miR-290 Expression Suppresses Breast Cancer Progression by Targeting the Metastasis Susceptibility Gene Arid4b 2013 ·Cancer Research ·Natalie Goldberger, Renard C. Walker, Chang Hee Kim, Scott F. Winter, Kent W. Hunter	33
12	Deletion of the Proline-Rich Region of the Murine Metastasis Susceptibility Gene Brd4 Promotes Epithelial-to-Mesenchymal Transition- and Stem Cell-Like Conversion 2011 ·Cancer Research ·Jude Alsarraj, Renard C. Walker, Joshua D. Webster, Thomas R. Geiger, Nigel P.S. Crawford, Richard J. Simpson, Keiko Ozato, Kent W. Hunter	56
13	DNA Methyltransferase Inhibitor, Zebularine, Delays Tumor Growth and Induces Apoptosis in a Genetically Engineered Mouse Model of Breast Cancer 2011 ·Molecular Cancer Therapeutics ·Min Chen, (unknown), Akbar Nawab, Sherry X. Yang, Lisa Dyer, Kevin D. Brown, Melinda G. Hollingshead, Kent W. Hunter, Frederic J. Kaye, Steven N. Hochwald, Víctor E. Márquez, Patricia S. Steeg, Maria Zajac‐Kaye	47
14	Expression Signature Developed from a Complex Series of Mouse Models Accurately Predicts Human Breast Cancer Survival 2009 ·Clinical Cancer Research ·Mei He, David P. Mangiameli, Stefan S. Kachala, Kent W. Hunter, John W. Gillespie, Xiaopeng Bian, Hui Shen, Steven K. Libutti	17
15	Polymorphisms of the SIPA1 gene and sporadic breast cancer susceptibility 2009 ·SHILAP Revista de lepidopterología ·Szu‐Min Hsieh, Robert A. Smith, (unknown), Kent W. Hunter, Lyn R. Griffiths	14
16	The Origins of Breast Cancer Prognostic Gene Expression Profiles 2008 ·Cancer Research ·Luanne Lukes, Nigel P.S. Crawford, Renard C. Walker, Kent W. Hunter	29
17	Mechanisms of metastasis 2008 ·Breast Cancer Research ·Kent W. Hunter, Nigel P.S. Crawford, Jude Alsarraj	221
18	Genotype × diet interactions in mice predisposed to mammary cancer. I. Body weight and fat 2008 ·Mammalian Genome ·Ryan R. Gordon, Kent W. Hunter, Peter Sørensen, Daniel Pomp	16
19	Global Expression Profiling Identifies Signatures of Tumor Virulence in MMTV-PyMT-Transgenic Mice 2004 ·Cancer Research ·Ting Qiu, Gadisetti V.R. Chandramouli, Kent W. Hunter, (unknown), Jeffrey E. Green, Edison T. Liu	89
20	The Development of a Highly Informative Mouse Simple Sequence Length Polymorphism (SSLP) Marker Set and Construction of a Mouse Family Tree Using Parsimony Analysis 2003 ·Genome Research ·P. Dane Witmer, Kimberly F. Doheny, (unknown), Corinne D. Boehm, (unknown), Janet L. Goldstein, (unknown), (unknown), (unknown), Elizabeth Pugh, Robert L. Nussbaum, Kent W. Hunter, (unknown), Lucy B. Rowe, Michael Brownstein	57

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact